The global hernia mesh devices market size was valued at USD 4769.4 million in 2021 and is expected to expand with a compounded annual growth rate (CAGR) of 6.54% from 2022 to 2030. Advancements such as self-fixating meshes and articulating fixation are likely to overcome the issues, which makes it a key factor for the growth in the adoption of hernia mesh devices. Smoking, poor nutrition, genetic factors, and changes in lifestyle are some of the factors contributing to the elevated incidence of hernias. High incidence of hernia globally and improved patient outcomes by using meshes, which reduce operative and recovery time, are some of the factors contributing to the growth. According to the U.S. FDA, more than a million hernia repairs are performed in the U.S. of which 800, 000 procedures are inguinal repairs. The prevalence of these hernias is high in developing countries with almost 0.95 million procedures being performed annually.
High incidence rate of hernia is creating demand for efficient hernia mesh devices, which is expected to be responsible for market growth. Furthermore, some of the advantages of using meshes in hernia repair are reduced chances of recurrence and alleviated pain, which is expected to accelerate market growth.
COVID-19 had a substantial impact on the hernia mesh devices market. In February 2019, the proportion of emergency repairs and operations was approximately 2.5% for inguinal hernias and 5.9% for incisional & umbilical hernias. In mid-March 2020, an announcement was made by the German government to stop elective surgical interventions. In addition, the number of hernia repairs registered by Herniamed during March 2020 was reduced substantially. The lowest cases of hernia repair were registered in April 2020, during which, hernia repair surgeries were equivalent to about 25% of those conducted from February to June 2019.
With the gradual decrease in COVID-19 cases after May 2020, restrictions executed on overall elective surgery across German hospitals were lifted, resulting in an increase in number of elective hernia repairs. Despite normalization of hospitalization policies in Germany, the caseload of hernia repairs in June 2020 was considerably lower than that in June 2019.
Technological advancements in hernia mesh devices have rapidly increased in recent years. Advancements such as articulating fixation devices and self-fixating (gripping) mesh are developed in order to overcome the problems occurring during the laparoscopic process. Also, such devices offer surgeons with better access to weak spots within the abdominal wall and enable them to securely place mesh at the desired body site, fostering the market growth.
Furthermore, several market players are aiming at developing and manufacturing highly-flexible and self-fixation hernia meshes where the mesh can be fixed at the hernia site without the usage of any glue or staples owing to the emergence of micro-grip adherence technology.
The hernia mesh devices market is segmented by hernia type into inguinal, incisional, femoral, and other hernias. Inguinal hernia dominated the market in 2021. Almost 80.0% of all hernias are inguinalin nature. Also, it is 10 times more common in men than women, which makes hernia repair expenditure mandatory. Other factors responsible for the dominance of this segment are patient feasibility due to tension-free procedures and more complications involved in the traditional operative techniques.
Femoral hernia is anticipated to hold a significant market share in 2021. The prevalence of femoral hernia is higher in women, especially in older women, as compared to men due to the wide shape of a female pelvis. Femoral hernia in children is very rare. It is a rare form of hernia when compared to an inguinal hernia. As per the UK government, approximately 1 out of 20 groin hernias is a femoral hernia, the rest being inguinal hernias.
On the basis of mesh type, the market is segmented into biological and synthetic. Although the price of biologic mesh is high compared to synthetic mesh, problems, such as inflammation and foreign body reaction, associated with synthetic mesh there is a shift of preference toward biological mesh. Thus, the biologic mesh is the faster-growing segment. Technological advancements are also anticipated to propel the biologic mesh market during the forecast period.
Synthetic segment captured the largest market share in 2021. Synthetic meshes dominated the hernia mesh market owing to their high product availability, easy availability of the product materials, and cost-effectiveness. The launch of new products, easy availability, and low prices were major reasons for the market domination of synthetic meshes in terms of the sales of mesh devices.
In September 2020, Surgical Innovation Associates received CE Mark approval for Dura Sorb, an absorbable mesh. The product provides scaffolding and mechanical support, offering an alternative to permanent synthetic or biological meshes. Moreover, synthetic meshes are economical for most patients and are a good alternative to biological meshes with the least number of postsurgical complications.
North America dominated the market in 2021 and is followed by Europe. The factors that are responsible for the big share are the large population suffering from the disease, improved healthcare facilities, sedentary lifestyle practices, and high adoption of surgical meshes as a treatment option. A favorable reimbursement scenario for hernia mesh is encouraging patients to opt for the surgery, open or laparoscopic. Patients have easy access to detailed reimbursement codes and ratios by the government as well as industry players.
Europe held a considerable market share in 2021. According to German Federal Statistical Agency, around 50,000 incisional hernia surgeries are performed each year in Germany. France has a significant prevalence of hernia with almost 154,000 people suffering from the condition. The most frequently used technique for hernia repair in the country is plug and patch. Thus increasing demand for hernia repair devices is anticipated to contribute to market growth.
Asia Pacific is expected to show rapid growth owing to the presence of a large patient pool, a remarkable increase in access and quality of healthcare, growth in awareness about target disorder management, and the presence of a wide range of medical solutions. Almost 63.0% of all repair surgeries are performed in Asia Pacific. This provides manufacturers with lucrative opportunities, especially for those who offer affordable products.
The industry is highly competitive with many players operating in the market. Large multinational companies with a wide product portfolio co-exist with companies that specialize in a particular product line. For instance, in March 2020, Johnson & Johnson’s Ethicon won the lawsuit against polypropylene hernia mesh. This mesh showed significant medical complications and damage when implanted in women’s body. This strategy helped the company strengthen its product offerings. Some of the prominent players in the global hernia mesh devices market include:
Johnson & Johnson Inc.
C. R. Bard, Inc.
W. L. Gore and Associates, Inc.
Atrium Medical (Getinge Group)
Life Cell Corporation
B. Braun Melsungen AG
Baxter International Inc.
Cook Medical
Hernia Mesh S.R.L
Report Attribute |
Details |
Market size value in 2022 |
USD 5010.05 million |
Revenue forecast in 2030 |
USD 8.3 billion |
Growth rate |
CAGR of 6.54% from 2022 to 2030 |
Base year for estimation |
2021 |
Actual estimates/Historic data |
2017 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2022 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors & trends |
Segments covered |
Hernia type, mesh type, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Japan; China; India; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE. |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global Hernia Mesh Devices Market based on the hernia type, mesh type, and region:
Hernia Type Outlook (Revenue, USD Million; 2017 - 2030)
Inguinal Hernia
Incisional Hernia
Femoral Hernia
Others
Mesh Type Outlook (Revenue, USD Million; 2017 - 2030)
Biologic Mesh
Synthetic Mesh
Regional Outlook (Revenue, USD Million; 2017 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
MEA
South Africa
Saudi Arabia
UAE
b. The global hernia mesh devices market size was estimated at USD 4769.4 million in 2021 and is expected to reach USD 5010.05 million in 2022.
b. The global hernia mesh devices market is expected to grow at a compound annual growth rate of 6.5% from 2022 to 2030 to reach USD 8.3 billion by 2030.
b. North America dominated the hernia mesh devices market with a share of 50.5% in 2021. This is attributable to improved healthcare facilities, sedentary lifestyle practices, and high adoption of surgical meshes as a treatment option.
b. Some key players operating in the hernia mesh devices market include Covidien plc, Medtronic, Inc., Ethicon, Inc.; C. R. Bard, Inc ; W. L. Gore and Associates, Inc.; Atrium Medical; LifeCell Corporation, and B. Braun Melsungen AG.
b. Key factors that are driving the market growth include a high incidence of hernia globally improved patient outcomes and technological advancements.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With COVID-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for COVID-19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.